United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Sai Life Sciences (NSE: SAILIFE) accelerates talent expansion to support complex drug development demand Sai Life Sciences Limited plans 700+ hires in FY27 as it scales R&D and manufacturing. Find out what this expansion signals for India’s CRDMO sector. bySrinathFebruary 22, 2026